Insulin pump therapy in transient neonatal diabetes mellitus
Annals of Pediatric Endocrinology & Metabolism
; : 148-151, 2013.
Article
em En
| WPRIM
| ID: wpr-178352
Biblioteca responsável:
WPRO
ABSTRACT
Neonatal diabetes mellitus (NDM) is a rare disease requiring insulin treatment. Its treatment is primarily focused on maintaining adequate glycemic control and avoiding hypoglycemia. Although insulin pump therapy is frequently administered to adults and children, there is no consensus on the use of insulin pumps in NDM. A 10 day-old female infant was referred to us with intrauterine growth retardation and poor weight gain. Hyperglycemia was noted, and continuous intravenous insulin infusion was initiated. However, the patient's serum glucose levels fluctuated widely, and maintaining the intravenous route became difficult within the following weeks. Continuous subcutaneous insulin infusion with an insulin pump was introduced on the twenty-fifth day of life, and good glycemic control was achieved without any notable adverse effects including hypoglycemia. We suggest that the insulin pump is a safe and effective mode for treating NDM and its early adoption may shorten the length of hospital stays in patients with NDM.
Palavras-chave
Texto completo:
1
Índice:
WPRIM
Assunto principal:
Glicemia
/
Sistemas de Infusão de Insulina
/
Aumento de Peso
/
Doenças Raras
/
Diabetes Mellitus
/
Retardo do Crescimento Fetal
/
Hiperglicemia
/
Hipoglicemia
/
Insulina
/
Tempo de Internação
Limite:
Female
/
Humans
/
Infant
/
Newborn
Idioma:
En
Revista:
Annals of Pediatric Endocrinology & Metabolism
Ano de publicação:
2013
Tipo de documento:
Article